Zosano Pharma Announces Presentation and Participation at the 31st Annual Roth Conference
12 3월 2019 - 5:30AM
Zosano Pharma Corporation (NASDAQ:ZSAN), a clinical-stage
biopharmaceutical company, today announced that its chairman,
president and chief executive officer, John Walker, will
participate in a panel titled “Drug Delivery” to be held on Monday,
March 18, 2019 at 10:30 am PT at the 31st Annual Roth Conference.
A live webcast of the panel will be available within the
company’s website at
http://ir.zosanopharma.com/events-presentations. In addition,
the company’s corporate presentation has been made available on the
conference website at http://wsw.com/webcast/roth33/zsan/ and on
the company’s website at
http://ir.zosanopharma.com/events-presentations for 30
days.
Forward-Looking StatementsThis press release
contains forward-looking statements regarding the expected timing
of a New Drug Application for Qtrypta (M207) and other future
events and expectations. Readers are urged to consider statements
that include the words "may," "will," "would," "could," "should,"
"might," "believes," "estimates," "projects," "potential,"
"expects," "plans," "anticipates," "intends," "continues,"
"forecast," "designed," "goal," "unaudited," "approximately" or the
negative of those words or other comparable words to be uncertain
and forward-looking. These statements are subject to risks and
uncertainties that are difficult to predict, and actual outcomes
may differ materially. These include risks and uncertainties,
without limitation, associated with the process of discovering,
developing and commercializing products that are safe and effective
for use as human therapeutics, risks inherent in the effort to
build a business around such products and other risks and
uncertainties described under the heading "Risk Factors" in the
Company's most recent annual report on Form 10-K. Although Zosano
believes that the expectations reflected in these forward-looking
statements are reasonable, we cannot in any way guarantee that the
future results, level of activity, performance or events and
circumstances reflected in forward-looking statements will be
achieved or occur. All forward-looking statements are based on
information currently available to Zosano and Zosano assumes no
obligation to update any such forward-looking statements.
Zosano Contact:Greg KitchenerChief Financial
Officer 510-745-1200
PR Contact:Sylvia Wheeler (or
Alexandra)swheeler@wheelhouselsa.com/asantos@wheelhouselsa.com
Zosano Pharma (NASDAQ:ZSAN)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Zosano Pharma (NASDAQ:ZSAN)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024